Insider · CIK 0001735529

Hefti Franz

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

Companies

Filings

CIK

0001735529

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−267K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−59.8K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−62.2K sh	—	—	0
2020-02-19	Prevail Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+62.2K sh	—	—	62,200

C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940

NEW YORK, NY, 10016